374 related articles for article (PubMed ID: 2357249)
1. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors.
Mazerska Z; Lukowicz J; Konopa J
Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249
[TBL] [Abstract][Full Text] [Related]
2. Comparison of antitumor properties of nitracrine and amsacrine analogs.
Mazerska Z; Chołody M; Lukowicz J; Wysocka-Skrzela B; Ledóchowski A
Arzneimittelforschung; 1987 Nov; 37(11):1276-81. PubMed ID: 3326605
[TBL] [Abstract][Full Text] [Related]
3. QSAR of acridines. II. Features of nitracrine analogs for high anti-tumor activity and selectivity on mice, searched by PCA and MRA methods.
Mazerska Z; Mazerski J; Ledóchowski A
Anticancer Drug Des; 1990 May; 5(2):169-87. PubMed ID: 2357263
[TBL] [Abstract][Full Text] [Related]
4. Some new aryl-sydnones: effects on murine tumours.
Grynberg N; Gomes R; Shinzato T; Echevarria A; Miller J
Anticancer Res; 1992; 12(3):1025-8. PubMed ID: 1320354
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of the novel nitrosourea S10036 in rodent tumors.
Filippeschi S; Colombo T; Bassani D; De Francesco L; Arioli P; D'Incalci M; Bartosek I; Guaitani A
Anticancer Res; 1988; 8(6):1351-4. PubMed ID: 3064716
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor activity of the components of a carminomycin complex].
Shorin VA; Bazhanov VS; Averbukh LA
Antibiotiki; 1977 Jan; 22(1):69-74. PubMed ID: 576573
[TBL] [Abstract][Full Text] [Related]
7. Isothiazolopyrimidines--new group of anticancer agents. I.
Machoń Z; Wieczorek J; Mordarski M
Arch Immunol Ther Exp (Warsz); 1987; 35(5):599-607. PubMed ID: 3455649
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor effect of a benzoylphenylurea derivative HO-221].
Nakajima T; Masuda H; Okamoto T; Watanabe M; Yokoyama K; Yamada N; Tsukagoshi S; Taguchi T
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2353-9. PubMed ID: 2260871
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of N alpha-benzyloxycarbonyl-N,N-bis-(2-halogenethyl)-hydrazide derivatives of amino acids.
Karaivanova MH; Zakhariev SG; Golovinsky EV
Neoplasma; 1980; 27(2):137-42. PubMed ID: 7393353
[TBL] [Abstract][Full Text] [Related]
10. The intercalative DNA binding and antitumor activity of some bis-acridines related to nitracrine.
Acheson RM; Taylor GN; Waring MJ; Haylock S; Abel G
Chem Biol Interact; 1985 May; 53(3):371-5. PubMed ID: 4006013
[No Abstract] [Full Text] [Related]
11. Screening study on Taiwan plants for antitumor activities.
King ML; Wang CT; Chang CF; Hsu HM; Wang SJ; Hartwell JL; Abbott BJ
Cancer Chemother Rep 2; 1974 Jul; 4(3):1-96. PubMed ID: 4842546
[No Abstract] [Full Text] [Related]
12. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.
Akaike Y; Arai Y; Taguchi H; Satoh H
Gan; 1982 Jun; 73(3):480-7. PubMed ID: 7129012
[TBL] [Abstract][Full Text] [Related]
13. 32P-post-labeling analysis of DNA adduct formation by antitumor drug nitracrine (Ledakrin) and other nitroacridines in different biological systems.
Bartoszek A; Konopa J
Biochem Pharmacol; 1989 Apr; 38(8):1301-12. PubMed ID: 2706021
[TBL] [Abstract][Full Text] [Related]
14. Antineoplastic activity of C-283 preparation (Ledakrin) in model experiments.
Radzikowski C
Mater Med Pol; 1976; 8(3):345-9. PubMed ID: 1034860
[No Abstract] [Full Text] [Related]
15. Antineoplastic activity of new linear hydrazine derivatives.
Fiszer-Maliszewska L; Peczyńska-Czoch W; Wieczorek J; Mordarski M; Balicki R; Nantka-Namirski P
Arch Immunol Ther Exp (Warsz); 1987; 35(2):225-35. PubMed ID: 3447537
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity and the effect of combined treatment with X-rays of an anticancer 1-nitro-9-aminoacridine derivative in L5178Y-R and L5178Y-S cells.
Szumiel I; Walicka M
Neoplasma; 1980; 27(6):697-702. PubMed ID: 7254425
[TBL] [Abstract][Full Text] [Related]
17. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR
Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392
[TBL] [Abstract][Full Text] [Related]
18. Potential anticancer agents. XXII. Pharmacological properties of some new triazene derivatives.
Ionescu D; Neagu V; Dobre V; Niculescu-Duvaz I
Neoplasma; 1981; 28(1):19-26. PubMed ID: 7279057
[TBL] [Abstract][Full Text] [Related]
19. [Antitumor activity of prospidin].
Sorkina IuA; Chernov VA; Grushina AA; Khramchenkova SP
Vopr Onkol; 1970; 16(7):83-6. PubMed ID: 5274101
[No Abstract] [Full Text] [Related]
20. Antitumor and immunosuppressive effects of mycophenolic acid derivatives.
Ohsugi Y; Suzuki S; Takagaki Y
Cancer Res; 1976 Aug; 36(8):2923-7. PubMed ID: 1277202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]